Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by LINDENSCHMIDT, R. C.
Right arrow Articles by WINROW, M. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LINDENSCHMIDT, R. C.
Right arrow Articles by WINROW, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

other

Effects of Oral Administration of a High-Molecular-Weight Crosslinked Polyacrylate in Rats

R. C. LINDENSCHMIDT, L. C. STONE, J. L. SEYMOUR, R. L. ANDERSON, P. A. FORSHEY and M. J. WINROW

The Procter & Gamble Company 6100 Center Hill Road, Cincinnati, Ohio 45224

Received October 25, 1989; accepted February 13, 1991

Effects of Oral Administration of a High-Molecular-Weight Crosslinked Polyacrylate in Rats.LINDENSCHMIDT, R. C, STONE, L. C, SEYMOUR, J. L., ANDERSON, R. L., FORSHEY, P. A., AND Winrow, M. J. (1991). Fundam. Appl. Toxicol. 17, 128-135. Oral feeding studies of a crosslinked, high-molecular-weight polyacrylate polymer (PA) were conducted to (1) characterize the biological effects following exposure to either 0, 300, 1000, or 3000 mg PA/kg–day for 93 days; (2) characterize the fecal and urinary mineral excretion at these same dose levels; and (3) monitor the absorption, distribution, and excretion (ADE) of radiolabeled PA following a single oral exposure. The sub-chronic study results indicate that dietary intake of up to 3000 mg/kg–day PA had no adverse histopathology, hematology, body weight, or clinical chemistry effects in rats. Dietary exposure to PA did, however, result in an elevation in urinary excretion of sodium and phosphorus, whereas excretion of magnesium, calcium, and potassium was lowered. A more detailed study demonstrated that although the urinary excretion of these minerals was changed, total recovery of the minerals (feces + urine), except for sodium, was not different from that for controls. An increase in sodium excretion was expected since PA was in the form of a sodium salt. The ADE studies following a single oral dose of PA indicate that the majority of dosed PA (91.9%) was excreted in the feces. As expected, a small percentage (3.5%) was absorbed, possibly metabolized, and excreted. In summary, the oral administration of high levels of PA resulted in (1) no histologicaL hematologjcal, or clinical chemistry changes; (2) no alteration in the overall mineral excretion (feces + urine) with the exception of sodium; and (3) primarily fecal excretion of orally administered PA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.